Eksentricity

• Funding Round: Atropos Health raises $33M in Series B, backed by McKesson, Merck, and Cencora Ventures.
• Core Technology: Geneva OS uses AI to generate clinical-grade evidence from real-world data, aiding personalized patient care.
• Strategic Initiatives: Expansion into life sciences, value-based care, and oncology with new funding.

Impact

1. AI-Driven Healthcare: Enhances clinical decision-making with AI-generated real-world evidence.
2. Improved Patient Outcomes: Personalized evidence aims to bridge the “evidence gap” in medical decisions.
3. Accelerated Drug Development: Partners with pharmaceutical companies to streamline clinical trials and R&D processes.
4. Global Expansion: Funding enables broader market reach and strategic growth initiatives.
5. Industry Leadership: Positions Atropos Health as a pioneer in applying generative AI to healthcare.

Read more